These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37865990)

  • 1. Genipin and pyrogallol: Two natural small molecules targeting the modulation of disordered proteins in Alzheimer's disease.
    Kim S; Hyun DG; Nam Y; Shin SJ; Im D; Kim HS; Leem SH; Park HH; Kim BH; Park YH; Cho E; Goddard WA; Kim DH; Kim HI; Moon M
    Biomed Pharmacother; 2023 Dec; 168():115770. PubMed ID: 37865990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genipin Attenuates Tau Phosphorylation and Aβ Levels in Cellular Models of Alzheimer's Disease.
    Li M; Cai N; Gu L; Yao L; Bi D; Fang W; Lin Z; Wu Y; Xu H; Li H; Hu Z; Xu X
    Mol Neurobiol; 2021 Aug; 58(8):4134-4144. PubMed ID: 33948899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual modulators of aggregation and dissociation of amyloid beta and tau: In vitro, in vivo, and in silico studies of Uncaria rhynchophylla and its bioactive components.
    Kim S; Nam Y; Shin SJ; Prajapati R; Shin SM; Kim MJ; Soo Kim H; Leem SH; Kim TJ; Park YH; Kim JJ; Choi JS; Moon M
    Biomed Pharmacother; 2022 Dec; 156():113865. PubMed ID: 36242849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual regulatory effects of neferine on amyloid-β and tau aggregation studied by in silico, in vitro, and lab-on-a-chip technology.
    Nam Y; Prajapati R; Kim S; Shin SJ; Cheong DY; Park YH; Park HH; Lim D; Yoon Y; Lee G; Jung HA; Park I; Kim DH; Choi JS; Moon M
    Biomed Pharmacother; 2024 Mar; 172():116226. PubMed ID: 38301421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Korean red ginseng polysaccharide as a potential therapeutic agent targeting tau pathology in Alzheimer's disease.
    Kim S; Shin SJ; Nam Y; Park YH; Kim BH; Park HH; Kumar V; Yoo DH; Lee YY; Hoe HS; Moon M
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130516. PubMed ID: 38423419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiophene-Based Dual Modulators of Aβ and Tau Aggregation.
    Ramesh M; Acharya A; Murugan NA; Ila H; Govindaraju T
    Chembiochem; 2021 Dec; 22(23):3348-3357. PubMed ID: 34546619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.
    Rhein V; Song X; Wiesner A; Ittner LM; Baysang G; Meier F; Ozmen L; Bluethmann H; Dröse S; Brandt U; Savaskan E; Czech C; Götz J; Eckert A
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20057-62. PubMed ID: 19897719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice.
    Davtyan H; Hovakimyan A; Kiani Shabestari S; Antonyan T; Coburn MA; Zagorski K; Chailyan G; Petrushina I; Svystun O; Danhash E; Petrovsky N; Cribbs DH; Agadjanyan MG; Blurton-Jones M; Ghochikyan A
    Alzheimers Res Ther; 2019 Dec; 11(1):107. PubMed ID: 31847886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.
    Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H
    Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
    Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
    ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
    Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
    CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-occurrence of Alzheimer's disease ß-amyloid and τ pathologies at synapses.
    Takahashi RH; Capetillo-Zarate E; Lin MT; Milner TA; Gouras GK
    Neurobiol Aging; 2010 Jul; 31(7):1145-52. PubMed ID: 18771816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease.
    Zhang T; Xia Y; Hu L; Chen D; Gan CL; Wang L; Mei Y; Lan G; Shui X; Tian Y; Li R; Zhang M; Lee TH
    Int J Biol Sci; 2022; 18(2):693-706. PubMed ID: 35002518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.